Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
339.31
Dollar change
+3.77
Percentage change
1.12
%
IndexS&P 500 P/E38.79 EPS (ttm)8.75 Insider Own6.18% Shs Outstand380.10M Perf Week2.91%
Market Cap129.26B Forward P/E25.31 EPS next Y13.40 Insider Trans-1.37% Shs Float357.42M Perf Month1.10%
Income3.36B PEG3.49 EPS next Q2.79 Inst Own80.23% Short Float1.15% Perf Quarter-3.66%
Sales20.96B P/S6.17 EPS this Y12.82% Inst Trans1.53% Short Ratio3.26 Perf Half Y15.55%
Book/sh50.33 P/B6.74 EPS next Y12.10% ROA8.82% Short Interest4.11M Perf Year24.56%
Cash/sh6.32 P/C53.70 EPS next 5Y11.11% ROE18.64% 52W Range249.98 - 361.41 Perf YTD13.31%
Dividend Est.3.12 (0.92%) P/FCF45.23 EPS past 5Y-2.45% ROI11.07% 52W High-6.11% Beta0.92
Dividend TTM3.10 (0.91%) Quick Ratio0.99 Sales past 5Y8.80% Gross Margin61.09% 52W Low35.73% ATR (14)5.70
Dividend Ex-DateJun 28, 2024 Current Ratio1.71 EPS Y/Y TTM27.45% Oper. Margin21.36% RSI (14)56.03 Volatility1.37% 1.77%
Employees52000 Debt/Eq0.70 Sales Y/Y TTM10.61% Profit Margin16.03% Recom1.80 Target Price379.49
Option/ShortYes / Yes LT Debt/Eq0.58 EPS Q/Q32.45% Payout36.98% Rel Volume1.48 Prev Close335.54
Sales Surprise2.71% EPS Surprise6.13% Sales Q/Q9.73% EarningsApr 30 AMC Avg Volume1.26M Price339.31
SMA202.55% SMA50-0.12% SMA2009.68% Trades Volume1,863,162 Change1.12%
Date Action Analyst Rating Change Price Target Change
May-22-24Upgrade Needham Hold → Buy $392
Jan-31-24Upgrade Canaccord Genuity Hold → Buy $315 → $360
Oct-20-23Initiated ROTH MKM Buy $345
Sep-05-23Upgrade BofA Securities Neutral → Buy $310 → $315
Mar-29-23Initiated UBS Neutral $287
Jan-25-23Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $284
Nov-01-22Downgrade Canaccord Genuity Buy → Hold $225 → $220
Oct-18-22Initiated Barclays Overweight $239
Oct-12-22Initiated Jefferies Buy $270
Today 02:15PM
May-23-24 06:30AM
May-22-24 09:36AM
May-16-24 04:21PM
May-09-24 08:00AM
07:58AM Loading…
07:58AM
May-07-24 02:10AM
May-02-24 01:02AM
May-01-24 04:12PM
11:53AM
11:32AM
09:55AM
09:55AM
09:54AM
09:54AM
09:51AM Loading…
09:51AM
09:44AM
09:39AM
09:36AM
09:13AM
08:27AM
08:26AM
07:55AM
07:25AM
06:08AM
03:27AM
Apr-30-24 08:57PM
06:11PM
06:00PM
05:32PM
05:25PM Loading…
05:25PM
04:55PM
04:43PM
04:25PM
04:16PM
04:05PM
Apr-25-24 09:15AM
Apr-24-24 08:23AM
07:50AM
06:25AM
Apr-23-24 01:38PM
10:00AM
Apr-22-24 06:08PM
Apr-21-24 08:30AM
Apr-18-24 09:35AM
Apr-05-24 04:42PM
Apr-01-24 04:05PM
Mar-29-24 09:40AM
Mar-27-24 10:54AM
Mar-26-24 04:05PM
08:02AM
03:10AM
Mar-22-24 10:39AM
Mar-21-24 11:39AM
10:00AM
07:15AM
Mar-19-24 02:23PM
Mar-07-24 04:23PM
Mar-06-24 08:46AM
Feb-29-24 10:31AM
12:04AM
Feb-28-24 02:10AM
Feb-22-24 05:25AM
Feb-18-24 01:26PM
Feb-15-24 12:07AM
Feb-13-24 02:41PM
08:00AM
05:06AM
Feb-07-24 08:00AM
Feb-05-24 08:00AM
Feb-01-24 03:03PM
10:08AM
Jan-31-24 07:29PM
01:19PM
10:50AM
10:35AM
09:53AM
08:10AM
07:59AM
Jan-30-24 11:06PM
06:30PM
05:15PM
04:45PM
04:44PM
04:28PM
04:05PM
Jan-29-24 08:22AM
07:30AM
02:53AM
Jan-25-24 10:50PM
09:15AM
Jan-24-24 11:25AM
Jan-22-24 05:16AM
05:00AM
Jan-18-24 08:50AM
Jan-17-24 08:00AM
Jan-15-24 10:03AM
Jan-12-24 03:49PM
01:55PM
Jan-10-24 08:35AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fletcher Robert SVP, Chief Legal OfficerMay 22 '24Sale332.992,007668,3088,896May 23 04:06 PM
Boehnlein Glenn SVP, Chief Financial OfficerMay 15 '24Sale327.6510,0003,276,51615,012May 16 04:16 PM
Stiles Spencer SGroup PresidentMar 21 '24Option Exercise0.00203055,602Mar 25 07:21 PM
Pierce James AndrewGroup PresidentMar 21 '24Option Exercise0.00203060,664Mar 25 07:16 PM
Menon VijuGroup PresidentMar 21 '24Option Exercise0.00158013,762Mar 25 07:11 PM
Lobo KevinChair and CEOMar 21 '24Option Exercise0.009050119,719Mar 25 06:58 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21 '24Option Exercise0.00120013,143Mar 25 06:54 PM
Fink M KathrynVP, Chief HR OfficerMar 21 '24Option Exercise0.0083013,710Mar 25 06:50 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 21 '24Option Exercise0.00256031,152Mar 25 06:45 PM
Becker Yin CVP, Chief Corp Affairs OfficerMar 21 '24Option Exercise0.0036029,898Mar 25 06:37 PM
Berry William E JrVP, Chief Accounting OfficerMar 08 '24Option Exercise154.141,480228,1275,155Mar 11 05:55 PM
Berry William E JrVP, Chief Accounting OfficerMar 07 '24Option Exercise108.3017,6601,912,58821,335Mar 11 05:55 PM
Berry William E JrVP, Chief Accounting OfficerMar 07 '24Sale358.487,6902,756,7303,675Mar 11 05:55 PM
Boehnlein Glenn SVP, Chief Financial OfficerFeb 09 '24Sale342.819,6003,290,95220,194Feb 12 04:09 PM
STRYKER RONDA EDirectorFeb 06 '24Sale339.9592,29631,376,0213,662,832Feb 07 05:33 PM
Becker Yin CVP, Chief Corp Affairs OfficerFeb 05 '24Option Exercise93.068,060750,06433,129Feb 07 05:00 PM
STRYKER RONDA EDirectorFeb 05 '24Sale342.90201,14668,973,3603,755,128Feb 07 05:33 PM
Golston Allan C.DirectorFeb 02 '24Option Exercise96.644,570441,64518,812Feb 06 05:24 PM
STRYKER RONDA EDirectorFeb 02 '24Option Exercise81.144,355353,3657,642Feb 06 05:16 PM
Golston Allan C.DirectorFeb 02 '24Sale341.003,2731,116,09314,242Feb 06 05:24 PM
Pierce James AndrewGroup PresidentJan 16 '24Option Exercise81.1410,230830,06257,999Jan 16 04:23 PM
Boehnlein Glenn SVP, Chief Financial OfficerJan 11 '24Option Exercise95.9960,0055,760,02268,981Jan 16 04:16 PM
Silvernail Andrew KDirectorDec 05 '23Option Exercise81.144,355353,36511,472Dec 07 04:57 PM
Datar Srikant M.DirectorDec 04 '23Option Exercise93.061,795167,0435,611Dec 05 04:25 PM
Datar Srikant M.DirectorDec 01 '23Sale298.22500149,1123,816Dec 05 04:25 PM
Becker Yin CVP, Chief Corp Affairs OfficerNov 28 '23Option Exercise81.148,875720,11830,806Nov 28 08:16 PM
Berry William E JrVP, Chief Accounting OfficerNov 28 '23Sale292.28573167,4772,909Nov 28 08:09 PM
Boehnlein Glenn SVP, Chief Financial OfficerNov 27 '23Option Exercise81.1411,955970,02916,570Nov 28 08:02 PM
Lobo KevinChair and CEONov 17 '23Option Exercise81.14160,21512,999,845241,249Nov 21 05:18 PM
Stiles Spencer SGroup PresidentNov 17 '23Option Exercise81.1411,090899,84353,732Nov 21 04:33 PM
Lobo KevinChair and CEONov 17 '23Sale287.9156,48316,261,81281,034Nov 21 05:18 PM
Datar Srikant M.DirectorNov 16 '23Sale291.92500145,9624,316Nov 16 05:56 PM
Datar Srikant M.DirectorNov 15 '23Sale287.50500143,7514,816Nov 16 05:56 PM
Datar Srikant M.DirectorNov 14 '23Sale287.57750215,6815,316Nov 16 05:56 PM
Menon VijuGroup PresidentSep 06 '23Sale289.005,0001,445,0006,994Sep 08 04:20 PM
Datar Srikant M.DirectorAug 10 '23Sale286.23750214,6716,066Aug 10 04:24 PM
Datar Srikant M.DirectorAug 08 '23Option Exercise93.062,000186,1207,467Aug 10 04:24 PM
Datar Srikant M.DirectorJun 01 '23Sale278.50500139,2505,467Jun 05 05:24 PM